International Union of Pharmacology. XXXV. The Glucagon Receptor Family
暂无分享,去创建一个
D. Drucker | L. Miller | D. Bataille | S. Dalle | B. Thorens | B. Göke | K. Mayo
[1] B. Göke,et al. Molecular cloning of a cDNA encoding for the GLP-1 receptor expressed in rat lung. , 2009, Experimental and clinical endocrinology.
[2] D. Singleton,et al. Structure-function analysis of a series of glucagon-like peptide-1 analogs. , 2009, The journal of peptide research : official journal of the American Peptide Society.
[3] D. Drucker. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. , 2003, Molecular endocrinology.
[4] P. Sexton,et al. Novel Receptor Partners and Function of Receptor Activity-modifying Proteins* , 2003, The Journal of Biological Chemistry.
[5] J. Holst,et al. Lower blood glucose, hyperglucagonemia, and pancreatic α cell hyperplasia in glucagon receptor knockout mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[6] Yazhou Li,et al. Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis* , 2003, The Journal of Biological Chemistry.
[7] T. Lybrand,et al. Interaction among four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus. , 2002, Molecular endocrinology.
[8] R. Pederson,et al. Glucose-dependent Insulinotropic Polypeptide Activates the Raf-Mek1/2-ERK1/2 Module via a Cyclic AMP/cAMP-dependent Protein Kinase/Rap1-mediated Pathway* , 2002, The Journal of Biological Chemistry.
[9] A. Schally,et al. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer. , 2002, The Journal of clinical endocrinology and metabolism.
[10] L. Miller,et al. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. , 2002, Cancer research.
[11] R. B. Merrifield,et al. Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling. , 2002, Biochemistry.
[12] M. Mattson,et al. Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4 , 2002, Journal of Pharmacology and Experimental Therapeutics.
[13] P. Light,et al. Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism. , 2002, Molecular endocrinology.
[14] A. Schally,et al. The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[15] G. Shull,et al. An alternate pathway of cAMP-stimulated Cl secretion across the NKCC1-null murine duodenum. , 2002, Gastroenterology.
[16] Chunling Zhang,et al. Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Yusta,et al. Glucagon-like Peptide-2 Receptor Activation Engages Bad and Glycogen Synthase Kinase-3 in a Protein Kinase A-dependent Manner and Prevents Apoptosis following Inhibition of Phosphatidylinositol 3-Kinase* , 2002, The Journal of Biological Chemistry.
[18] C. Saper,et al. Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons. , 2002, The Journal of clinical investigation.
[19] Yuichiro Yamada,et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity , 2002, Nature Medicine.
[20] J. Holst,et al. Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats , 2002, Regulatory Peptides.
[21] S. Dib,et al. Role of the Gly40Ser Mutation in the Glucagon Receptor Gene in Brazilian Patients With Type 2 Diabetes Mellitus , 2002, Pancreas.
[22] M. Matsubara,et al. A composite hormone response element regulates transcription of the rat GHRH receptor gene. , 2002, Endocrinology.
[23] J. Holst,et al. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study , 2002, The Lancet.
[24] V. Hruby,et al. Assessment of the role of interstitial glucagon in the acute glucose secretory responsiveness of in situ pancreatic beta-cells. , 2002, Diabetes.
[25] P. Mullis,et al. Decreased expression of the GHRH receptor gene due to a mutation in a Pit-1 binding site. , 2002, Molecular endocrinology.
[26] N. Greig,et al. A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells. , 2002, The Journal of pharmacology and experimental therapeutics.
[27] R. Pederson,et al. Dipeptidyl peptidase IV-resistant [D-Ala(2)]glucose-dependent insulinotropic polypeptide (GIP) improves glucose tolerance in normal and obese diabetic rats. , 2002, Diabetes.
[28] J. Egan,et al. The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. , 2002, The Journal of clinical endocrinology and metabolism.
[29] A. Kuki,et al. Human glucagon receptor antagonists based on alkylidene hydrazides. , 2002, Bioorganic & medicinal chemistry letters.
[30] J. Livingston,et al. Discovery of 5-hydroxyalkyl-4-phenylpyridines as a new class of glucagon receptor antagonists. , 2002, Bioorganic & medicinal chemistry letters.
[31] P. Flatt,et al. Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide. , 2002, Biochemical and biophysical research communications.
[32] D. Bataille,et al. Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology. , 2002, Diabetes.
[33] L. Miller,et al. Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma. , 2002, Gastroenterology.
[34] J. Sturis,et al. Bedtime administration of NN2211, a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. , 2002, Diabetes.
[35] R. Horikawa. [Isolated GH deficiency due to inactivating mutation of GHRH receptor]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.
[36] D. Drucker. Biological actions and therapeutic potential of the glucagon-like peptides. , 2002, Gastroenterology.
[37] M. Zdravkovic,et al. The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men , 2002, Diabetologia.
[38] J. Stock,et al. Glycemic control in mice with targeted disruption of the glucagon receptor gene. , 2002, Biochemical and biophysical research communications.
[39] J. Holst,et al. The truncated metabolite GLP-2 (3–33) interacts with the GLP-2 receptor as a partial agonist , 2002, Regulatory Peptides.
[40] O. Chepurny,et al. Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic β-cell lines for use in transplantation , 2002, Cell and Tissue Research.
[41] T. Shibasaki,et al. Critical Role of cAMP-GEFII·Rim2 Complex in Incretin-potentiated Insulin Secretion* , 2001, The Journal of Biological Chemistry.
[42] Anthony J Harmar,et al. Family-B G-protein-coupled receptors , 2001, Genome Biology.
[43] J. Holst,et al. Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes. , 2001, Diabetes.
[44] K. Petersen,et al. Effects of a novel glucagon receptor antagonist (Bay 27–9955) on glucagon-stimulated glucose production in humans , 2001, Diabetologia.
[45] M. Beinborn,et al. A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain. , 2001, The Journal of biological chemistry.
[46] O. Chepurny,et al. cAMP‐regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+‐induced Ca2+ release in INS‐1 pancreatic β‐cells , 2001, The Journal of physiology.
[47] D. Smith,et al. Oxyntomodulin inhibits food intake in the rat. , 2001, Endocrinology.
[48] M. Bjerknes,et al. Modulation of specific intestinal epithelial progenitors by enteric neurons , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. Holst,et al. Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. , 2001, Diabetes care.
[50] D. Hörsch,et al. Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. , 2001, Molecular endocrinology.
[51] A. Astrup,et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans. , 2001, The Journal of clinical endocrinology and metabolism.
[52] D. Drucker. Development of glucagon-like peptide-1-based pharmaceuticals as therapeutic agents for the treatment of diabetes. , 2001, Current pharmaceutical design.
[53] A. Kuki,et al. Identification of alkylidene hydrazides as glucagon receptor antagonists. , 2001, Journal of medicinal chemistry.
[54] J. Jameson,et al. Absence of constitutively activating mutations in the GHRH receptor in GH-producing pituitary tumors. , 2001, The Journal of clinical endocrinology and metabolism.
[55] R. Pederson,et al. A New Pathway for Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor Signaling , 2001, The Journal of Biological Chemistry.
[56] B. Yusta,et al. Glucagon-like Peptide (GLP)-2 Action in the Murine Central Nervous System Is Enhanced by Elimination of GLP-1 Receptor Signaling* , 2001, The Journal of Biological Chemistry.
[57] M. Thorner,et al. Molecular cloning of ovine and bovine growth hormone-releasing hormone receptors: the ovine receptor is C-terminally truncated. , 2001, Endocrinology.
[58] R. Pederson,et al. Identification of a bioactive domain in the amino-terminus of glucose-dependent insulinotropic polypeptide (GIP). , 2001, Biochimica et biophysica acta.
[59] R. Pederson,et al. Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats. , 2001, Diabetes.
[60] T. G. Burns,et al. A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. , 2001, The Journal of pediatrics.
[61] D. Irwin. Molecular evolution of proglucagon , 2001, Regulatory Peptides.
[62] M. Schwartz,et al. GLP-2α accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion , 2001 .
[63] A. Korytko,et al. Differential GH-releasing hormone regulation of GHRH receptor mRNA expression in the rat pituitary. , 2001, American journal of physiology. Endocrinology and metabolism.
[64] C. Östenson,et al. Different domains in the third intracellular loop of the GLP-1 receptor are responsible for Gαs and Gαi/Gαo activation , 2001 .
[65] J. Holst,et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. , 2001, Gastroenterology.
[66] D. Irwin,et al. Evolution of receptors for proglucagon-derived peptides: isolation of frog glucagon receptors. , 2001, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.
[67] J. Holst,et al. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. , 2001, Diabetes.
[68] B. Harding,et al. Absence of mutations in the growth hormone (GH)‐releasing hormone receptor gene in GH‐secreting pituitary adenomas , 2001, Clinical endocrinology.
[69] R. Kineman,et al. The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback. , 2001, Endocrinology.
[70] H. Hassan. Biological activities of two porcine growth hormone-releasing hormone receptor isoforms. , 2001, Archives of biochemistry and biophysics.
[71] M. Wheeler,et al. Biological activities of glucagon-like peptide-1 analogues in vitro and in vivo. , 2001, Biochemistry.
[72] D. Drucker,et al. Minireview: the glucagon-like peptides. , 2001, Endocrinology.
[73] C. Foged,et al. The growth hormone-releasing hormone receptor: desensitisation following short-term agonist exposure. , 2001, Acta Pharmacologica et Toxicologica.
[74] P. Godfrey,et al. Regulation of the pituitary somatotroph cell by GHRH and its receptor. , 2000, Recent progress in hormone research.
[75] M. Wheeler,et al. Characterization of glucagon-like peptide-1 receptor-binding determinants. , 2000, Journal of molecular endocrinology.
[76] L. Miller,et al. Dual Contacts between Peptide Agonist Ligands and the Secretin Receptor Directly Established by Photoaffinity Labeling , 2000, Annals of the New York Academy of Sciences.
[77] B. Yusta,et al. The Glucagon-like Peptide-2 Receptor Mediates Direct Inhibition of Cellular Apoptosis via a cAMP-dependent Protein Kinase-independent Pathway* , 2000, The Journal of Biological Chemistry.
[78] Y. Asmann,et al. Structural insights into the amino-terminus of the secretin receptor: I. Status of cysteine and cystine residues. , 2000, Molecular pharmacology.
[79] L. Miller,et al. Cross-chimeric analysis of selectivity of secretin and VPAC(1) receptor activation. , 2000, The Journal of pharmacology and experimental therapeutics.
[80] Yasuhiro Sunaga,et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis , 2000, Nature Cell Biology.
[81] J. Holst,et al. Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. , 2000, Endocrinology.
[82] B. Yusta,et al. Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine. , 2000, Endocrinology.
[83] J. Holst,et al. Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: Distribution and binding of I.V. injected 125-I-GLP-2 , 2000, Regulatory Peptides.
[84] H. Vaudry,et al. Molecular evolution of the growth hormone-releasing hormone/pituitary adenylate cyclase-activating polypeptide gene family. Functional implication in the regulation of growth hormone secretion. , 2000, Journal of molecular endocrinology.
[85] J. Holst,et al. Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected 125I-GLP-2 , 2000, Peptides.
[86] A. Schally,et al. Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[87] B. Yusta,et al. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. , 2000, Gastroenterology.
[88] B Perkins,et al. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. , 2000, Diabetes.
[89] D. Dransfield,et al. Glucose-dependent insulinotropic peptide signaling pathways in endothelial cells , 2000, Peptides.
[90] B. Yusta,et al. Structural determinants for activity of glucagon-like peptide-2. , 2000, Biochemistry.
[91] D. Moller,et al. New approaches in the treatment of type 2 diabetes. , 2000, Current opinion in chemical biology.
[92] D. Pipeleers,et al. Glucagon receptors on human islet cells contribute to glucose competence of insulin release , 2000, Diabetologia.
[93] J. Holst,et al. In vivo and in vitro degradation of glucagon-like peptide-2 in humans. , 2000, The Journal of clinical endocrinology and metabolism.
[94] R. B. Merrifield,et al. Selective Stabilization of the High Affinity Binding Conformation of Glucagon Receptor by the Long Splice Variant of Gαs * , 2000, The Journal of Biological Chemistry.
[95] P. J. Larsen,et al. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake , 2000, Nature Medicine.
[96] W. Chance,et al. Maintaining Gut Integrity During Parenteral Nutrition of Tumor-Bearing Rats: Effects of Glucagon-Like Peptide 2 , 2000, Nutrition and cancer.
[97] P. Yang,et al. Glucagon-like peptide-2 enhances intestinal epithelial barrier function of both transcellular and paracellular pathways in the mouse , 2000, Gut.
[98] H. Vaudry,et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. , 2000, Pharmacological reviews.
[99] P. Flatt,et al. Improved glycaemic control in obese diabetic ob/ob mice using N-terminally modified gastric inhibitory polypeptide. , 2000, The Journal of endocrinology.
[100] J. Palazzo,et al. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2. , 2000, Journal of pediatric surgery.
[101] S. Bonner-Weir,et al. Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. , 2000, Diabetes.
[102] D. Drucker,et al. Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[103] H. Rasmussen,et al. Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. , 2000, Endocrinology.
[104] M. Schwartz,et al. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion. , 2000, Journal of pediatric surgery.
[105] S. Woods,et al. Targeted gene disruption in endocrine research--the case of glucagon-like peptide-1 and neuroendocrine function. , 2000, Endocrinology.
[106] D. Drucker,et al. Neuroendocrine Function and Response to Stress in Mice with Complete Disruption of Glucagon-Like Peptide-1 Receptor Signaling1. , 2000, Endocrinology.
[107] R. Kineman. Antitumorigenic actions of growth hormone-releasing hormone antagonists. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[108] J. Miyazaki,et al. Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[109] M. Wolfe,et al. GIP biology and fat metabolism. , 1999, Life sciences.
[110] J. Habener,et al. The glucagon-like peptides. , 1999, Endocrine reviews.
[111] A. Schally,et al. Antagonistic Analogs of Growth Hormone-releasing Hormone: New Potential Antitumor Agents , 1999, Trends in Endocrinology & Metabolism.
[112] B. Yusta,et al. Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. , 1999, American journal of physiology. Endocrinology and metabolism.
[113] L. Josefsson,et al. Evidence for kinship between diverse G-protein coupled receptors. , 1999, Gene.
[114] E. Blázquez,et al. Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. , 1999, American journal of physiology. Endocrinology and metabolism.
[115] S. Grinstein,et al. Identification of Glucagon-like Peptide-2 (GLP-2)-activated Signaling Pathways in Baby Hamster Kidney Fibroblasts Expressing the Rat GLP-2 Receptor* , 1999, The Journal of Biological Chemistry.
[116] S. Mojsov,et al. Functional studies of a glucagon receptor isolated from frog Rana tigrina rugulosa: implications on the molecular evolution of glucagon receptors in vertebrates , 1999, FEBS letters.
[117] P. Godfrey,et al. Printed in U.S.A. Copyright © 1999 by The Endocrine Society The Rat Growth Hormone-Releasing Hormone Receptor Gene: Structure, Regulation, and Generation of Receptor Isoforms with Different Signaling Properties* , 1999 .
[118] H. Bode,et al. Glucagon-Like Peptide 1 Elevates Cytosolic Calcium in Pancreaticβ -Cells Independently of Protein Kinase A1. , 1999, Endocrinology.
[119] B. Yusta,et al. Biologic properties and therapeutic potential of glucagon-like peptide-2. , 1999, JPEN. Journal of parenteral and enteral nutrition.
[120] R. Pederson,et al. Characterization of the Carboxyl-terminal Domain of the Rat Glucose-dependent Insulinotropic Polypeptide (GIP) Receptor , 1999, The Journal of Biological Chemistry.
[121] G. Morel,et al. Restricted Presence of the Growth Hormone-Releasing Hormone Receptor to Somatotropes in Rat and Human Pituitaries , 1999, Neuroendocrinology.
[122] I. De Meester,et al. CD26, let it cut or cut it down. , 1999, Immunology today.
[123] C. Cotton,et al. The human secretin receptor gene: genomic organization and promoter characterization , 1999, FEBS letters.
[124] L. Miller,et al. Identification of an Interaction between Residue 6 of the Natural Peptide Ligand and a Distinct Residue within the Amino-terminal Tail of the Secretin Receptor* , 1999, The Journal of Biological Chemistry.
[125] T. Sakmar,et al. Two Cytoplasmic Loops of the Glucagon Receptor Are Required to Elevate cAMP or Intracellular Calcium* , 1999, The Journal of Biological Chemistry.
[126] D. Drucker,et al. Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. , 1999, Gastroenterology.
[127] C. Tortorella,et al. Gastric inhibitory polypeptide stimulates glucocorticoid secretion in rats, acting through specific receptors coupled with the adenylate cyclase-dependent signaling pathway , 1999, Peptides.
[128] P. Gaudreau,et al. Differential in Vivo Regulation of the Pituitary Growth Hormone-Releasing Hormone (GHRH) Receptor by GHRH in Young and Aged Rats. , 1999, Endocrinology.
[129] S. Germain,et al. Encapsulated, Genetically Engineered Cells, Secreting Glucagon‐like Peptide‐1 for the Treatment of Non‐insulin‐dependent Diabetes Mellitus , 1999, Annals of the New York Academy of Sciences.
[130] J. Habener,et al. cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). , 1999, The Journal of biological chemistry.
[131] D. Drucker. Glucagon-like Peptide 2 , 1999, Trends in Endocrinology & Metabolism.
[132] P. MacDonald,et al. Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs. , 1999, Diabetes.
[133] C. Beglinger,et al. rapid communication Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2 , 2022 .
[134] K. Chihara,et al. Cloning and Characterization of the 5′-Flanking Region of the Human Growth Hormone-releasing Hormone Receptor Gene* , 1999, The Journal of Biological Chemistry.
[135] F. Ashcroft,et al. Miniglucagon (Glucagon 19–29), a Potent and Efficient Inhibitor of Secretagogue-induced Insulin Release through a Ca2+Pathway* , 1999, The Journal of Biological Chemistry.
[136] P. Flatt,et al. NH2-terminally modified gastric inhibitory polypeptide exhibits amino-peptidase resistance and enhanced antihyperglycemic activity. , 1999, Diabetes.
[137] B. Gaylinn. Molecular and cell biology ofthe growth hormone-releasing hormone receptor , 1999 .
[138] B. Gaylinn. Molecular and cell biology of the growth hormone-releasing hormone receptor. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[139] F. Gracia‐Navarro,et al. Growth Hormone (GH)-Releasing Factor Differentially Activates Cyclic Adenosine 3',5'-Monophosphate- and Inositol Phosphate-Dependent Pathways to Stimulate GH Release in Two Porcine Somatotrope Subpopulations. , 1999, Endocrinology.
[140] M. Svoboda,et al. Identification of a Glucose Response Element in the Promoter of the Rat Glucagon Receptor Gene* , 1999, The Journal of Biological Chemistry.
[141] M. Levine,et al. Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. , 1999, The Journal of clinical endocrinology and metabolism.
[142] D. Drucker,et al. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[143] J. Schrezenmeir,et al. Biological activity of GLP-1-analogues with N-terminal modifications , 1999, Regulatory Peptides.
[144] H. Trusheim,et al. Gene Expression of the Human Glucagon-Like Peptide-1 Receptor Is Regulated by Sp1 and Sp3. , 1999, Endocrinology.
[145] M. Wolfe,et al. Structure of the rat glucose-dependent insulinotropic polypeptide receptor gene , 1999, Peptides.
[146] R. Burcelin,et al. Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1. , 1999, Metabolism: clinical and experimental.
[147] A. Schally,et al. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[148] P. Shughrue,et al. Distribution of pre‐pro‐glucagon and glucagon‐like peptide‐1 receptor messenger RNAs in the rat central nervous system , 1999, The Journal of comparative neurology.
[149] L. Miller,et al. Demonstration of a Direct Interaction between Residue 22 in the Carboxyl-terminal Half of Secretin and the Amino-terminal Tail of the Secretin Receptor Using Photoaffinity Labeling* , 1999, The Journal of Biological Chemistry.
[150] P. Stevens,et al. Functional GHRH receptor carboxyl terminal isoforms in normal and dwarf (dw) rats. , 1998, Journal of molecular endocrinology.
[151] R. Carr,et al. Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists. , 1998, Journal of medicinal chemistry.
[152] W. MacNaughton,et al. GLP-2 augments the adaptive response to massive intestinal resection in rat. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[153] B. Göke,et al. Contribution of a PS1‐like element to the tissue‐ and cell‐specific expression of the human GLP‐1 receptor gene , 1998, FEBS letters.
[154] G. Ramadori,et al. A synthetic glucagon-like peptide-1 analog with improved plasma stability. , 1998, The Journal of endocrinology.
[155] J. Blanco,et al. Dipeptidyl‐peptidase IV‐β , 1998 .
[156] T. Kishimoto,et al. Inhibition of signal transduction by a splice variant of the growth hormone-releasing hormone receptor expressed in human pituitary adenomas. , 1998, Metabolism: clinical and experimental.
[157] C. Delporte,et al. Molecular cloning and in vitro properties of the recombinant rabbit secretin receptor , 1998, Peptides.
[158] J. Dunphy,et al. Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression 1 This work was supported by a grant from the Crohn's and Colitis Foundation of America. 1 , 1998, Molecular and Cellular Endocrinology.
[159] J. Gromada,et al. Glucagon-mediated Ca2+signaling in BHK cells expressing cloned human glucagon receptors. , 1998, American journal of physiology. Cell physiology.
[160] K. Mayo,et al. Identification of binding domains of the growth hormone-releasing hormone receptor by analysis of mutant and chimeric receptor proteins. , 1998, Molecular endocrinology.
[161] C. Tseng,et al. The cysteine of the cytoplasmic tail of glucose-dependent insulinotropic peptide receptor mediates its chronic desensitization and down-regulation , 1998, Molecular and Cellular Endocrinology.
[162] B. Göke,et al. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. , 1998, The Journal of clinical investigation.
[163] T. Hansen,et al. Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells , 1998, Diabetologia.
[164] M. Caron,et al. A Role for Receptor Kinases in the Regulation of Class II G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[165] L. Miller,et al. Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. , 1998, Gastroenterology.
[166] H. Schulte,et al. Structure and regulation of the human growth hormone-releasing hormone receptor gene. , 1998, Molecular endocrinology.
[167] S. Amselem,et al. Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. , 1998, The Journal of clinical endocrinology and metabolism.
[168] J. Holst,et al. Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity , 1998, Diabetologia.
[169] D. Drucker. Glucagon-Like Peptides , 1998, Diabetes.
[170] C. Donaldson,et al. Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies. , 1998, Journal of medicinal chemistry.
[171] B. Göke,et al. Five Out of Six Tryptophan Residues in the N-Terminal Extracellular Domain of the Rat GLP-1 Receptor Are Essential for its Ability to Bind GLP-1 , 1997, Peptides.
[172] M. Tota,et al. Fluorescein-Trp25-Exendin-4, a Biologically Active Fluorescent Probe for the Human GLP-1 Receptor , 1997, Peptides.
[173] B. Göke,et al. Cloning and Characterization of the 5′ Flanking Sequences (Promoter Region) of the Human GLP-1 Receptor Gene , 1997, Peptides.
[174] D. Drucker,et al. Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2. , 1997, American journal of physiology. Gastrointestinal and liver physiology.
[175] J. Takahara,et al. Gene regulation of growth hormone-releasing hormone and its receptor. , 1997, Endocrine journal.
[176] H. Maheshwari,et al. The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH‐releasing hormone receptor gene , 1997, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[177] Yihong Wang,et al. Novel signal transduction and peptide specificity of glucagon‐like peptide receptor in 3T3‐L1 adipocytes , 1997, Journal of cellular physiology.
[178] J. Livingston,et al. Role of the Glucagon Receptor COOH-Terminal Domain in Glucagon-Mediated Signaling and Receptor Internalization , 1997, Diabetes.
[179] W. Chance,et al. Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2. , 1997, The American journal of physiology.
[180] C. Widmann,et al. Internalization and homologous desensitization of the GLP-1 receptor depend on phosphorylation of the receptor carboxyl tail at the same three sites. , 1997, Molecular endocrinology.
[181] D. Drucker,et al. Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. , 1997, The American journal of physiology.
[182] D. Drucker,et al. Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV , 1997, Nature Biotechnology.
[183] J. Holst,et al. The pathogenesis of NIDDM involves a defective expression of the GIP receptor , 1997, Diabetologia.
[184] Y. Seino,et al. Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and -insensitive pathways. , 1997, Biochemical and biophysical research communications.
[185] K. Mayo,et al. Glucocorticoids regulate pituitary growth hormone-releasing hormone receptor messenger ribonucleic acid expression. , 1997, Endocrinology.
[186] R. Pederson,et al. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor. , 1997, Endocrinology.
[187] D. Drucker,et al. Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. , 1997, The American journal of physiology.
[188] J. Habener,et al. Insulinotropic Glucagon-Like Peptide I Receptor Expression in Glucagon-Producing α-Cells of the Rat Endocrine Pancreas , 1997, Diabetes.
[189] R. Pederson,et al. GIP6–30amide contains the high affinity binding region of GIP and is a potent inhibitor of GIP1–42action in vitro , 1997, Regulatory Peptides.
[190] L. Lin,et al. A point mutation in the glucose-dependent insulinotropic peptide receptor confers constitutive activity. , 1997, Biochemical and biophysical research communications.
[191] D. Drucker,et al. Biological determinants of intestinotrophic properties of GLP-2 in vivo. , 1997, The American journal of physiology.
[192] R. Kineman,et al. Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels. , 1997, Endocrinology.
[193] T. Ogihara,et al. Tissue-Specific and Glucose-Dependent Expression of Receptor Genes for Glucagon and Glucagon-Like Peptide-1 (GLP-1) , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[194] A. Korytko,et al. Thyroid hormone and glucocorticoid regulation of pituitary growth hormone-releasing hormone receptor gene expression. , 1997, The Journal of endocrinology.
[195] P. J. Larsen,et al. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem , 1997, Neuroscience.
[196] J. Fuselier,et al. Structural Simplification of Potent Growth Hormone‐Releasing Hormone Analogs: Implications for Other Members of the VIP/GHRH/PACAP Family a , 1996, Annals of the New York Academy of Sciences.
[197] S. Chambers,et al. HYPOTHESIS: GLUCAGON RECEPTOR GLYCINE TO SERINE MISSENSE MUTATION CONTRIBUTES TO ONE IN 20 CASES OF ESSENTIAL HYPERTENSION * , 1996, Clinical and experimental pharmacology & physiology.
[198] T. Usdin,et al. Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. , 1996, The Journal of clinical investigation.
[199] P. Godfrey,et al. The Growth‐Hormone‐Releasing Hormone Receptor: Signal Transduction, Gene Expression, and Physiological Function in Growth Regulation a , 1996, Annals of the New York Academy of Sciences.
[200] K. Tsuda,et al. Identification of Two Missense Mutations in the GIP Receptor Gene: A Functional Study and Association Analysis with NIDDM: No Evidence of Association with Japanese NIDDM Subjects , 1996, Diabetes.
[201] J. Christophe,et al. Glucagon and Its Receptor in Various Tissues , 1996, Annals of the New York Academy of Sciences.
[202] I. Merchenthaler,et al. Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. , 1996, Endocrinology.
[203] A. Joyner,et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.
[204] D. Smith,et al. Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on alpha-TSH cells. , 1996, Endocrinology.
[205] M. Byrne,et al. Human Studies with Glucagon‐like‐peptide‐1: Potential of the Gut Hormone for Clinical Use , 1996, Diabetic medicine : a journal of the British Diabetic Association.
[206] L. Miller,et al. Role of Receptor Phosphorylation in Desensitization and Internalization of the Secretin Receptor* , 1996, The Journal of Biological Chemistry.
[207] R. Pederson,et al. Investigation of Glucose-dependent Insulinotropic Polypeptide(1-42) and Glucagon-like Peptide-1-(7-36) Degradation in Vitro by Dipeptidyl Peptidase IV Using Matrix-assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry , 1996, The Journal of Biological Chemistry.
[208] C. Cheeseman,et al. The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport. , 1996, The American journal of physiology.
[209] H. Bonjer,et al. Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. , 1996, The Journal of clinical endocrinology and metabolism.
[210] D. Drucker,et al. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[211] N. Miki,et al. Regulation of pituitary growth hormone-releasing factor (GRF) receptor gene expression by GRF. , 1996, Biochemical and Biophysical Research Communications - BBRC.
[212] Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP): Effect of a GIP-specific receptor antagonist , 1996, Regulatory Peptides.
[213] J. Habener,et al. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. , 1996, Endocrinology.
[214] L. Miller,et al. Multiple Extracellular Loop Domains Contribute Critical Determinants for Agonist Binding and Activation of the Secretin Receptor* , 1996, The Journal of Biological Chemistry.
[215] K. Lam,et al. Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen. , 1996, Neuroendocrinology.
[216] A. Torsello,et al. Growth hormone-releasing factor (GRF) regulates expression of its own receptor. , 1996, Endocrinology.
[217] O. Pescovitz,et al. A novel peptide from the growth hormone releasing hormone gene stimulates Sertoli cell activity. , 1996, Endocrinology.
[218] A. Korytko,et al. Developmental regulation of pituitary growth hormone-releasing hormone receptor gene expression in the rat. , 1996, Endocrinology.
[219] D. Pipeleers,et al. Expression and Functional Activity of Glucagon, Glucagon-Like Peptide I, and Glucose-Dependent Insulinotropic Peptide Receptors in Rat Pancreatic Islet Cells , 1996, Diabetes.
[220] D. Smith,et al. A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.
[221] H. Hsiung,et al. Characterization of growth hormone-releasing hormone (GHRH) binding to cloned porcine GHRH receptor , 1995, Peptides.
[222] B. Göke,et al. Characterization of GIP(1–30) and GIP(1–42) as stimulators of proinsulin gene transcription , 1995, Peptides.
[223] N. Miki,et al. Thyroid hormone regulation of gene expression of the pituitary growth hormone-releasing factor receptor. , 1995, Biochemical and biophysical research communications.
[224] N. Miki,et al. Sexually dimorphic expression of pituitary growth hormone-releasing factor receptor in the rat. , 1995, Biochemical and biophysical research communications.
[225] R. B. Merrifield,et al. Characterization of Deletion and Truncation Mutants of the Rat Glucagon Receptor , 1995, The Journal of Biological Chemistry.
[226] L. Miller,et al. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor. , 1995, Molecular pharmacology.
[227] P. J. Larsen,et al. Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites , 1995, The European journal of neuroscience.
[228] R. Burcelin,et al. Cloning and sequence analysis of the murine glucagon receptor-encoding gene. , 1995, Gene.
[229] B. Chow,et al. Localization of the gene encoding the secretin receptor, SCTR, on human chromosome 2q14.1 by fluorescence in situ hybridization and chromosome morphometry. , 1995, Genomics.
[230] P. Froguel,et al. Cloning, Functional Expression, and Chromosomal Localization of the Human Pancreatic Islet Glucose-Dependent Insulinotropic Polypeptide Receptor , 1995, Diabetes.
[231] Y. Shigeyoshi,et al. Regional distribution of growth hormone-releasing hormone (GHRH) receptor mRNA in the rat brain. , 1995, Endocrinology.
[232] Y. Seino,et al. Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA. , 1995, Genomics.
[233] J. Brown,et al. Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. , 1995, Endocrinology.
[234] T. Ohnishi,et al. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas. , 1995, The Journal of clinical endocrinology and metabolism.
[235] J. Takahara,et al. Differential gene expression of growth hormone (GH)-releasing hormone (GRH) and GRH receptor in various rat tissues. , 1995, Endocrinology.
[236] R. Bretzel,et al. The Effects of Glucagon‐like Peptide‐I (GLP‐I) on Hormone Secretion from Isolated Human Pancreatic Islets , 1995, Pancreas.
[237] R. Collu,et al. Identification of human growth hormone-releasing hormone receptor splicing variants. , 1995, The Journal of clinical endocrinology and metabolism.
[238] R. Pederson,et al. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. , 1995, Endocrinology.
[239] J. Habener,et al. Activation of a cAMP-regulated Ca-Signaling Pathway in Pancreatic -Cells by the Insulinotropic Hormone Glucagon-like Peptide-1 (*) , 1995, The Journal of Biological Chemistry.
[240] B. Chow. Molecular cloning and functional characterization of a human secretin receptor. , 1995, Biochemical and biophysical research communications.
[241] E. Nishimura,et al. Regulation of Glucagon Receptor mRNA in Cultured Primary Rat Hepatocytes by Glucose and cAMP (*) , 1995, The Journal of Biological Chemistry.
[242] J. Vilardaga,et al. Properties of chimeric secretin and VIP receptor proteins indicate the importance of the N-terminal domain for ligand discrimination. , 1995, Biochemical and biophysical research communications.
[243] L. Miller,et al. Critical Contributions of Amino-terminal Extracellular Domains in Agonist Binding and Activation of Secretin and Vasoactive Intestinal Polypeptide Receptors. STUDIES OF CHIMERIC RECEPTORS (*) , 1995, The Journal of Biological Chemistry.
[244] B. Göke,et al. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. , 1995, Endocrine reviews.
[245] E. Nishimura,et al. Regulation of glucagon and glucagon-like peptide-1 receptor messenger ribonucleic acid expression in cultured rat pancreatic islets by glucose, cyclic adenosine 3',5'-monophosphate, and glucocorticoids. , 1995, Endocrinology.
[246] S. Ohashi,et al. Evidence that glucagon stimulates insulin secretion through its own receptor in rats , 1995, Diabetologia.
[247] G. Velho,et al. A missense mutation in the glucagon receptor gene is associated with non–insulin–dependent diabetes mellitus , 1995, Nature Genetics.
[248] S. Mojsov,et al. Tissue‐specific expression of the human receptor for glucagon‐like peptide‐I: brain, heart and pancreatic forms have the same deduced amino acid sequences , 1995, FEBS letters.
[249] B. Göke,et al. Reduction of the Incretin Effect in Rats by the Glucagon-Like Peptide 1 Receptor Antagonist Exendin (9–39) Amide , 1995, Diabetes.
[250] B. Göke,et al. Glycosylation of the GLP-1 receptor is a prerequisite for regular receptor function , 1994, Peptides.
[251] S. Seino,et al. Hamster gastric inhibitory polypeptide receptor expressed in pancreatic islets and clonal insulin-secreting cells: its structure and functional properties. , 1994, Biochemical and biophysical research communications.
[252] A. Schally,et al. Synthesis and biological activities of highly potent antagonists of growth hormone-releasing hormone. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[253] H. Kim,et al. Synthesis and expression of a gene for the rat glucagon receptor. Replacement of an aspartic acid in the extracellular domain prevents glucagon binding. , 1994, The Journal of biological chemistry.
[254] P. Robberecht,et al. Relative quantitative analysis of glucagon receptor mRNA in rat tissues , 1994, Molecular and Cellular Endocrinology.
[255] S. Chua,et al. Human growth hormone-releasing hormone receptor (GHRHR) maps to a YAC at Chromosome 7p15 , 1994, Mammalian Genome.
[256] J. Holst,et al. Rat parietal cell receptors for GLP-1-(7-36) amide: northern blot, cross-linking, and radioligand binding. , 1994, The American journal of physiology.
[257] M. Thorner,et al. Photoaffinity cross-linking to the pituitary receptor for growth hormone-releasing factor. , 1994, Endocrinology.
[258] J. Vincent,et al. Ion channels and the signal transduction pathways in the regulation of growth hormone secretion , 1994, Trends in Endocrinology & Metabolism.
[259] B. Göke,et al. Signal transduction of the GLP‐1‐receptor cloned from a human insulinoma , 1994, FEBS letters.
[260] F. Grant,et al. The human glucagon receptor encoding gene: structure, cDNA sequence and chromosomal localization. , 1994, Gene.
[261] M. Stoffel,et al. Localization of the glucagon receptor gene to human chromosome band 17q25. , 1994, Genomics.
[262] R. B. Merrifield,et al. Identification of an essential serine residue in glucagon: implication for an active site triad. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[263] C. Strader,et al. Cloning and expression of a human glucagon receptor. , 1994, Biochemical and biophysical research communications.
[264] M. Brownstein,et al. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. , 1993, Endocrinology.
[265] L. Miller,et al. Intrinsic photoaffinity labeling of native and recombinant rat pancreatic secretin receptors. , 1993, Gastroenterology.
[266] Shaoping Deng,et al. Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9–39) an Antagonist of the Receptor , 1993, Diabetes.
[267] C. Strader,et al. Cloning and functional expression of a human glucagon-like peptide-1 receptor. , 1993, Biochemical and biophysical research communications.
[268] M. Nakata,et al. Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity. , 1993, Endocrinology.
[269] M. Permutt,et al. Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor. , 1993, Endocrinology.
[270] B. Göke,et al. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. , 1993, The Journal of biological chemistry.
[271] M. Stoffel,et al. Human Glucagon-Like Peptide-1 Receptor Gene: Localization to Chromosome Band 6p21 by Fluorescence In Situ Hybridization and Linkage of a Highly Polymorphic Simple Tandem Repeat DNA Polymorphism to Other Markers on Chromosome 6 , 1993, Diabetes.
[272] Aldons J. Lusis,et al. Molecular basis of the little mouse phenotype and Implications for cell type-specific growth , 1993, Nature.
[273] Nancy A. Jenkins,et al. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function , 1993, Nature Genetics.
[274] H. Hsiung,et al. Structure and functional expression of a complementary DNA for porcine growth hormone-releasing hormone receptor , 1993, Neuropeptides.
[275] S. Shenolikar,et al. Control of cholecystokinin receptor dephosphorylation in pancreatic acinar cells. , 1993, The Journal of biological chemistry.
[276] B. Gallwitz,et al. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. , 1993, European journal of biochemistry.
[277] J. Holst,et al. Biological Effects and Metabolic Rates of Glucagonlike Peptide-1 7–36 Amide and Glucagonlike Peptide-1 7–37 in Healthy Subjects Are Indistinguishable , 1993, Diabetes.
[278] P. Robberecht,et al. A cDNA construct allowing the expression of rat hepatic glucagon receptors. , 1993, Biochemical and biophysical research communications.
[279] F J Grant,et al. Expression cloning and signaling properties of the rat glucagon receptor. , 1993, Science.
[280] M. Wolfe,et al. Glucose-dependent insulinotropic peptide: structure of the precursor and tissue-specific expression in rat. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[281] R. B. Merrifield,et al. The role of histidine-1 in glucagon action. , 1993, Archives of biochemistry and biophysics.
[282] M. Rosenfeld,et al. Pit-1-dependent expression of the receptor for growth hormone releasing factor mediates pituitary cell growth , 1992, Nature.
[283] M. Dufau,et al. Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function. , 1992, Endocrinology.
[284] R. Campbell,et al. Evolution of the growth hormone-releasing factor (GRF) family of peptides. , 1992, Growth regulation.
[285] K. Mayo. Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone. , 1992, Molecular endocrinology.
[286] P. Leymarie,et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. , 1992, The New England journal of medicine.
[287] B. Thorens. Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[288] B. Göke,et al. Solubilization of active GLP‐1 (7–36)amide receptors from RINm5F plasma membranes , 1992, FEBS letters.
[289] A. S. French,et al. FIVE pS ANION CHANNELS IN HUMAN AIRWAY EPITHELIAL CELLS , 1992 .
[290] K. Catt,et al. Expression of the growth hormone-releasing hormone gene and its peptide product in the rat ovary. , 1992, Endocrinology.
[291] Y. Kaziro,et al. Molecular cloning and expression of a cDNA encoding the secretin receptor. , 1991, The EMBO journal.
[292] A. Leiter,et al. The secretin gene: evolutionary history, alternative splicing, and developmental regulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[293] R. Knight,et al. Production of a growth hormone-releasing hormone-like peptide and its mRNA by human lymphocytes. , 1991, Neuroendocrinology.
[294] R. Campbell,et al. GRF analogs and fragments: Correlation between receptor binding, activity and structure , 1991, Peptides.
[295] B. Göke,et al. Characterization of glucagon‐like peptide‐I(7–36)amide receptors of rat lung membranes by covalent cross‐linking , 1991, FEBS letters.
[296] J. Habener,et al. Functional receptors for the insulinotropic hormone glucagon‐like peptide‐I(7–37) on a somatostatin secreting cell line , 1991, FEBS letters.
[297] R. B. Merrifield,et al. Position 9 replacement analogs of glucagon uncouple biological activity and receptor binding. , 1991, The Journal of biological chemistry.
[298] R. Jensen,et al. Reduced peptide bond pseudopeptide analogues of secretin. A new class of secretin receptor antagonists. , 1991, The Journal of biological chemistry.
[299] T. Abribat,et al. Characterization of [125I-Tyr10]human growth hormone-releasing factor(1–44) amide binding to rat pituitary: evidence for high and low affinity classes of sites , 1990, Brain Research.
[300] J. Kraicer,et al. Effect of growth hormone-releasing factor on phosphoinositide hydrolysis in somatotrophs , 1990, Molecular and Cellular Endocrinology.
[301] B. Göke,et al. Characterization of receptors for glucagon‐like peptide‐1(7–36) amide on rat lung membranes , 1990, FEBS letters.
[302] D. Bataille,et al. Glucagon-(19-29) exerts a biphasic action on the liver plasma membrane Ca2+ pump which is mediated by G proteins. , 1990, The Journal of biological chemistry.
[303] E. Blázquez,et al. Characterization of high‐affinity receptors for truncated glucagon‐like peptide‐1 in rat gastric glands , 1990, FEBS letters.
[304] A. Leiter,et al. Secretin: structure of the precursor and tissue distribution of the mRNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[305] S. Asa,et al. Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation. , 1989, Endocrinology.
[306] S. Suhr,et al. Mouse growth-hormone-releasing hormone: precursor structure and expression in brain and placenta. , 1989, Molecular endocrinology.
[307] P. Chomczyński,et al. Cloning and characterization of mouse growth hormone-releasing hormone (GRH) complementary DNA: increased GRH messenger RNA levels in the growth hormone-deficient lit/lit mouse. , 1989, Molecular endocrinology.
[308] B. Göke,et al. Signal transmission after GLP-1(7-36)amide binding in RINm5F cells. , 1989, The American journal of physiology.
[309] S. Kadowaki,et al. Mechanism for increase of gastrin release by secretin in Zollinger-Ellison syndrome. , 1989, Gastroenterology.
[310] L. Frohman,et al. Dipeptidylpeptidase IV and trypsin-like enzymatic degradation of human growth hormone-releasing hormone in plasma. , 1989, The Journal of clinical investigation.
[311] J. Conlon,et al. Characterization of the receptor for glucagon-like peptide-1(7-36)amide on plasma membranes from rat insulinoma-derived cells by covalent cross-linking. , 1989, Journal of molecular endocrinology.
[312] D. Drucker,et al. Glucagon gene expression in vertebrate brain. , 1988, The Journal of biological chemistry.
[313] J. Holst,et al. Effect of truncated glucagon‐like peptide 1 on cAMP in rat gastric glands and HGT‐1 human gastric cancer cells , 1988, FEBS letters.
[314] R. Hammer,et al. Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. , 1988, Molecular endocrinology.
[315] O. Pescovitz,et al. Identification of a rat GHRH-like substance and its messenger RNA in rat testis. , 1988, Endocrinology.
[316] J. Holst,et al. Naturally occurring products of proglucagon 111-160 in the porcine and human small intestine. , 1988, The Journal of biological chemistry.
[317] M. Thorner,et al. Intracellular calcium concentration and growth hormone secretion in individual somatotropes: effects of growth hormone-releasing factor and somatostatin. , 1988, Endocrinology.
[318] J. Lauder,et al. Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical study , 1988, The Journal of comparative neurology.
[319] J. Conlon,et al. Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells. , 1988, The Journal of endocrinology.
[320] K. Shima,et al. Identification and localization of glucagon-like peptide-1 and its receptor in rat brain. , 1987, Endocrinology.
[321] R. Bruzzone,et al. Secretin stimulates cyclic AMP and inositol trisphosphate production in rat pancreatic acinar tissue by two fully independent mechanisms. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[322] D. Drucker,et al. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[323] D. Bataille,et al. A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon , 1987, Nature.
[324] J. Holst,et al. Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. , 1986, Endocrinology.
[325] L. Orci,et al. Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. , 1986, The Journal of biological chemistry.
[326] V. Hruby,et al. Activation of two signal-transduction systems in hepatocytes by glucagon , 1986, Nature.
[327] L. Swanson,et al. Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[328] D. Cocchi,et al. Growth hormone-releasing factor does not stimulate phosphoinositides breakdown in primary cultures of rat and human pituitary cells. , 1986, Acta endocrinologica.
[329] R. Hammer,et al. Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth , 1985, Nature.
[330] D. Coy,et al. Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. , 1985, Endocrinology.
[331] F. Morel,et al. Glucagon receptors along the nephron: [125I]glucagon binding in rat tubules , 1985, Pflügers Archiv.
[332] L. Swanson,et al. The distribution of growth‐hormone‐releasing factor (GRF) immunoreactivity in the central nervous system of the rat: An immunohistochemical study using antisera directed against rat hypothalamic GRF , 1985, The Journal of comparative neurology.
[333] I. Mühlhauser,et al. Incidence and Management of Severe Hypoglycemia in 434 Adults with Insulin-dependent Diabetes Mellitus , 1985, Diabetes Care.
[334] R. Evans,et al. Characterization of cDNA and genomic clones encoding the precursor to rat hypothalamic growth hormone-releasing factor , 1985, Nature.
[335] W. Vale,et al. Binding sites for growth hormone releasing factor on rat anterior pituitary cells , 1985, Nature.
[336] G. Velicelebi,et al. Specific binding of synthetic human pancreatic growth hormone releasing factor (1-40-OH) to bovine anterior pituitaries. , 1985, Biochemical and biophysical research communications.
[337] N. Hoosein,et al. Human glucagon‐like peptides 1 and 2 activate rat brain adenylate cyclase , 1984, FEBS letters.
[338] N. Ueno,et al. Synthesis and invitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor , 1984 .
[339] N. Ling,et al. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[340] N. Hoosein,et al. Identification of glucagon receptors in rat brain. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[341] R. Iyengar,et al. Structural analysis of the hepatic glucagon receptor. Identification of a guanine nucleotide-sensitive hormone-binding region. , 1984, The Journal of biological chemistry.
[342] A. Schally,et al. Immunocytochemical localization of growth hormone-releasing factor in the rat hypothalamus. , 1984, Endocrinology.
[343] N. Ling,et al. Growth hormone-releasing factor regulates growth hormone mRNA in primary cultures of rat pituitary cells. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[344] D. Coy,et al. Super-active analogs of growth hormone-releasing factor (1-29)-amide. , 1984, Biochemical and biophysical research communications.
[345] M. Thorner,et al. Human pancreatic GRF stimulates phosphatidylinositol labeling in cultured anterior pituitary cells. , 1983, The American journal of physiology.
[346] R. Evans,et al. Expression-cloning and sequence of a cDNA encoding human growth hormone-releasing factor , 1983, Nature.
[347] R. Evans,et al. Transcriptional regulation of growth hormone gene expression by growth hormone-releasing factor , 1983, Nature.
[348] A. Kumar,et al. Mammalian pancreatic preproglucagon contains three glucagon-related peptides. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[349] W. Vale,et al. Characterization of rat hypothalamic growth hormone-releasing factor , 1983, Nature.
[350] G. Bell,et al. Hamster preproglucagon contains the sequence of glucagon and two related peptides , 1983, Nature.
[351] W. Vale,et al. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour , 1982, Nature.
[352] N. Ling,et al. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. , 1982, Science.
[353] K. Kovacs,et al. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. , 1982, The Journal of clinical investigation.
[354] W. Creutzfeldt,et al. Gastric inhibitory polypeptide. , 1980, Clinics in gastroenterology.
[355] J. Gardner,et al. Interaction of peptides related to secretin with hormone receptors on pancreatic acinar cells. , 1976, Gastroenterology.
[356] L. Orci,et al. Identification of glucagon-producing cells (A cells) in dog gastric mucosa , 1976, The Journal of cell biology.
[357] W. Beamer,et al. Inherited ateliotic dwarfism in mice. Characteristics of the mutation, little, on chromosome 6. , 1976, The Journal of heredity.
[358] J. Brown,et al. Stimulation of insulin secretion by gastric inhibitory polypeptide in man. , 1973, The Journal of clinical endocrinology and metabolism.
[359] L. Stimmler. Glucagon and growth hormone. , 1973, British medical journal.
[360] J. Isenberg,et al. Unusual effect of secretin on serum gastrin, serum calcium, and gastric acid secretion in a patient with suspected Zollinger-Ellison syndrome. , 1972, Gastroenterology.
[361] L. Birnbaumer,et al. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. 3. Binding of glucagon: method of assay and specificity. , 1971, The Journal of biological chemistry.
[362] L. Birnbaumer,et al. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. , 1971, The Journal of biological chemistry.
[363] R. Rosenblum. Glucagon and the heart. , 1970, British medical journal.
[364] R. Unger,et al. Entero-insular axis. , 1969, Archives of internal medicine.
[365] V. Marks,et al. Interrelationship of Glucagon, Insulin and Glucose: The Insulinogenic Effect of Glucagon , 1966, Diabetes.
[366] J. Beck,et al. Stimulation of Release of Insulin by an Extract of Intestinal Mucosa , 1966, Diabetes.
[367] V. Mutt,et al. Structure of Porcine Secretin. I. Degradation with Trypsin and Thrombin. Sequence of the Tryptic Peptides. The C-Terminal Residue* , 1965 .
[368] R. Unger,et al. Localization of glucagon in the alpha cells in the pancreatic islet by immunofluorescent technics. , 1962, Diabetes.
[369] O. Behrens,et al. The Amino Acid Sequence of Glucagon , 1956, Diabetes.
[370] A. Kenny. Extractable glucagon of the human pancreas. , 1955, The Journal of clinical endocrinology and metabolism.
[371] E. Sutherland. The effect of the hyperglycemic factor of the pancreas and of the epinephrine on glycogenolys. , 1950, Omnia medica.
[372] R. S. Allen,et al. AQUEOUS EXTRACTS OF PANCREAS: IV. The Yield of Crude Insulin by Perfusion, Percolation and Simple Extraction , 1924 .
[373] C. Kimball,et al. AQUEOUS EXTRACTS OF PANCREAS III. SOME PRECIPITATION REACTIONS OF INSULIN , 1923 .
[374] E. Starling,et al. PRELIMINARY COMMUNICATION ON THE CAUSATION OF THE SO-CALLED "PERIPHERAL REFLEX SECRETION" OF THE PANCREAS. , 1902 .
[375] Yazhou Li,et al. Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. , 2003, The Journal of biological chemistry.
[376] J. Sturis,et al. Bedtime Administration of NN 2211 , a Long-Acting GLP-1 Derivative , Substantially Reduces Fasting and Postprandial Glycemia in Type 2 Diabetes , 2002 .
[377] G. Morel,et al. Localization and regulation of a functional GHRH receptor in the rat renal medulla. , 2002, Endocrinology.
[378] L. Plotnick,et al. Three new mutations in the gene for the growth hormone (gh)-releasing hormone receptor in familial isolated gh deficiency type ib. , 2001, The Journal of clinical endocrinology and metabolism.
[379] B. Yusta,et al. Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor. , 2001, Cancer research.
[380] Ű. Langel,et al. Different domains in the third intracellular loop of the GLP-1 receptor are responsible for Galpha(s) and Galpha(i)/Galpha(o) activation. , 2001, Biochimica et Biophysica Acta.
[381] M. Schwartz,et al. GLP-2alpha accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion. , 2001, Journal of pediatric surgery.
[382] H. Holloway,et al. Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent. , 2001, Endocrinology.
[383] J. Zalvide,et al. Growth hormone-releasing hormone stimulates mitogen-activated protein kinase. , 2000, Endocrinology.
[384] P. Godfrey,et al. The rat growth hormone-releasing hormone receptor gene: structure, regulation, and generation of receptor isoforms with different signaling properties. , 1999, Endocrinology.
[385] R. Pederson,et al. Glucose-dependent insulinotropic polypeptide stimulation of lipolysis in differentiated 3T3-L1 cells: wortmannin-sensitive inhibition by insulin. , 1999, Endocrinology.
[386] D. Bataille,et al. Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes. , 1999, Endocrinology.
[387] B. Yusta,et al. Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[388] Y. Kato,et al. Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo. , 1999, Journal of pediatric surgery.
[389] D. Bataille,et al. Glicentin and Oxyntomodulin Modulate Both the Phosphoinositide and Cyclic Adenosine Monophosphate Signaling Pathways in Gastric Myocytes* *This work was supported by La Fondation pour la Recherche Médicale. , 1999, Endocrinology.
[390] B. Göke,et al. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A. , 1999, Endocrinology.
[391] B. Göke,et al. Gene expression of the human glucagon-like peptide-1 receptor is regulated by Sp1 and Sp3. , 1999, Endocrinology.
[392] E. Nillni,et al. Posttranslational processing of progrowth hormone-releasing hormone. , 1999, Endocrinology.
[393] M. Thorner,et al. The mutant growth hormone-releasing hormone (GHRH) receptor of the little mouse does not bind GHRH. , 1999, Endocrinology.
[394] D. Pipeleers,et al. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors. , 1998, Diabetes.
[395] B. Göke,et al. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. , 1997, Proceedings of the Association of American Physicians.
[396] 安田浩一朗. HAMSTER GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR EXPRESSED IN PANCREATIC ISLETS AND CLONAL INSULINSECRETING CELLS: ITS STRUCTURE AND FUNCTIONAL PROPERTIES(膵ラ島およびインスリン分泌細胞株に発現するハムスターガストリックインヒビトリーポリペプチド受容体の構造と機能について) , 1997 .
[397] B. Ozenberger,et al. Investigation of growth hormone releasing hormone receptor structure and activity using yeast expression technologies. , 1997, Journal of receptor and signal transduction research.
[398] R. Pederson,et al. GIP(6-30amide) contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro. , 1997, Regulatory peptides.
[399] D. Bataille. Oxyntomodulin and Its Related Peptides , 1996 .
[400] D. Bataille. Preproglucagon and Its Processing , 1996 .
[401] S. Chua,et al. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse , 1996, Nature Genetics.
[402] C. Widmann,et al. Structure and Function of the Glucagon-Like Peptide-1 Receptor , 1996 .
[403] A. R. Friedman,et al. Synthetic Analogues of Growth Hormone Releasing Factor (GHRF) with Improved Pharmaceutical Properties , 1996 .
[404] S. Suhr,et al. Growth hormone-releasing hormone: synthesis and signaling. , 1995, Recent progress in hormone research.
[405] M. Thorner,et al. Assignment of the human growth hormone-releasing hormone receptor gene (GHRHR) to 7p14 by in situ hybridization. , 1994, Genomics.
[406] M. Thorner,et al. Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. , 1993, Molecular endocrinology.
[407] J. Holst,et al. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. , 1993, The Journal of clinical investigation.
[408] I. Valverde,et al. Presence and characterization of glucagon-like peptide-1(7-36) amide receptors in solubilized membranes of rat adipose tissue. , 1993, Endocrinology.
[409] M. Wheeler,et al. The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37). , 1993, Endocrinology.
[410] J. Habener,et al. Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells. , 1992, Endocrinology.
[411] J. Kraicer,et al. Free intracellular Ca2+ concentration ([Ca2+]i) and growth hormone release from purified rat somatotrophs. I. GH-releasing factor-induced Ca2+ influx raises [Ca2+]i. , 1991, Endocrinology.
[412] P. Lindström,et al. The correlation between calcium outflow and growth hormone release in perifused rat somatotrophs. , 1990, Endocrinology.
[413] N. Vamvakopoulos,et al. Expression and localization of growth hormone-releasing hormone messenger ribonucleic acid in rat placenta: in vitro secretion and regulation of its peptide product. , 1990, Endocrinology.
[414] W. Creutzfeldt,et al. Gastrointestinal peptides and insulin secretion. , 1987, Diabetes/metabolism reviews.
[415] G. Merriam,et al. Growth hormone releasing hormone. , 1986, Annual review of physiology.
[416] N. Ling,et al. Synthesis and in vitro bioactivity of C-terminal deleted analogs of human growth hormone-releasing factor. , 1984, Biochemical and biophysical research communications.
[417] Graeme I. Bell,et al. Exon duplication and divergence in the human preproglucagon gene , 1983, Nature.
[418] T. Claus,et al. Glucagon and Gluconeogenesis , 1983 .
[419] W. Stalmans. Glucagon and Liver Glycogen Metabolism , 1983 .
[420] R. Goodman,et al. Pancreatic preproglucagon cDNA contains two glucagon-related coding sequences arranged in tandem. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[421] L. Frohman,et al. Ectopic production of growth hormone-releasing factor by carcinoid and pancreatic islet tumors associated with acromegaly. , 1981, Progress in clinical and biological research.
[422] Eaton Rp. Glucagon and Lipoprotein Regulation in Man , 1977 .
[423] E. Starling,et al. On the causation of the so-called ‘peripheral reflex secretion’ of the pancreas. (Preliminary communication.) , 1902, Proceedings of the Royal Society of London.